Published in J Clin Microbiol on April 01, 1983
Characterization of a beta-lactamase found in Eikenella corrodens. Antimicrob Agents Chemother (1991) 0.97
Restriction endonuclease analysis of Eikenella corrodens. J Clin Microbiol (1990) 0.94
Identification of a streptomycin resistance gene and a partial Tn3 transposon coding for a beta-lactamase in a periodontal strain of Eikenella corrodens. Antimicrob Agents Chemother (1992) 0.90
In vitro activities of a new des-fluoroquinolone, BMS 284756, and seven other antimicrobial agents against 151 isolates of Eikenella corrodens. Antimicrob Agents Chemother (2002) 0.78
Aerobic bacteria cultured from the mouth of the American opossum (Didelphis virginiana) with reference to bacteria associated with bite infections. J Clin Microbiol (1990) 0.75
A study of the bacteria associated with advancing periodontitis in man. J Clin Periodontol (1979) 7.56
Eikenella corrodens, a recently recognized pathogen: infections in medical-surgical patients and in association with methylphenidate abuse. Medicine (Baltimore) (1974) 2.61
Haemophili and related bacteria in the human oral cavity. Arch Oral Biol (1975) 2.52
Bacteroides corrodens isolated from bacteriaemias. J Pathol Bacteriol (1967) 1.71
Eikenella corrodens endocarditis: report of cure in two cases. Mayo Clin Proc (1974) 1.52
Agar medium for use in susceptibility testing of bacteria from human periodontal pockets. Antimicrob Agents Chemother (1979) 1.32
Susceptibility of Eikenella corrodens to newer beta-lactam antibiotics. Antimicrob Agents Chemother (1980) 1.18
Infections following clenched-fist injury: a new perspective. J Hand Surg Am (1978) 1.05
Eikenella corrodens isolated in oral infections of dental origin. Oral Surg Oral Med Oral Pathol (1977) 0.99
Selective medium for isolation of Eikenella corrodens from periodontal lesions. J Clin Microbiol (1978) 0.93
Eikenella corrodens: a new pathogen. Oral Surg Oral Med Oral Pathol (1979) 0.92
Sinus infection due to Eikenella corrodens. Arch Otolaryngol (1978) 0.91
Experimental Eikenella corrodens endocarditis in rabbits. Infect Immun (1979) 0.89
Eikenella corrodens: a clinical problem. J Am Dent Assoc (1975) 0.85
Comparative growth of Eikenella corrodens on 15 media in three atmospheres of incubation. J Clin Microbiol (1981) 0.84
Aetiology of antimicrobial-agent-associated colitis. Lancet (1978) 5.91
Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group. N Engl J Med (1999) 5.82
Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev (1992) 3.32
Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. Ann Intern Med (1987) 2.79
Bacteriology of human and animal bite wounds. J Clin Microbiol (1978) 2.66
Evaluation of the E test for susceptibility testing of anaerobic bacteria. J Clin Microbiol (1991) 2.59
Staphylococcus intermedius in canine gingiva and canine-inflicted human wound infections: laboratory characterization of a newly recognized zoonotic pathogen. J Clin Microbiol (1989) 2.24
MRI findings in Susac's syndrome. Neurology (2003) 2.17
Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Ann Neurol (1992) 2.07
Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology (1993) 1.98
Neurosyphilis in acquired immunodeficiency syndrome. Arch Neurol (1989) 1.96
HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology (1994) 1.86
Determinants of survival in progressive multifocal leukoencephalopathy. Neurology (2009) 1.77
Saccharomyces cerevisiae infections in man. Sabouraudia (1984) 1.76
Evaluation of a novel specimen transport system (Venturi Transystem) for anaerobic bacteria. Clin Infect Dis (1997) 1.75
Effect of carbon dioxide on in vitro susceptibility of anaerobic bacteria to erythromycin. Antimicrob Agents Chemother (1981) 1.73
Cerebellar degeneration associated with human immunodeficiency virus infection. Neurology (1998) 1.69
Characterization of saccharolytic Bacteroides and Prevotella isolates from infected dog and cat bite wounds in humans. J Clin Microbiol (1997) 1.68
Role of anaerobic bacteria in bite-wound infections. Rev Infect Dis (1984) 1.66
Asymptomatic and neurologically symptomatic HIV-seropositive individuals: prospective evaluation with cranial MR imaging. Radiology (1991) 1.64
Early penetration of the blood-brain-barrier by HIV. Neurology (1988) 1.62
Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals. Antimicrob Agents Chemother (1985) 1.56
Acceleration of HIV dementia with methamphetamine and cocaine. J Neurovirol (2001) 1.56
Neurosyphilis in HIV-positive and HIV-negative patients: neuroimaging findings. AJNR Am J Neuroradiol (1995) 1.56
Infections caused by Klebsiella ozaenae: a changing disease spectrum. J Clin Microbiol (1978) 1.50
Characterization of a beta-lactamase from Clostridium clostridioforme. J Antimicrob Chemother (1994) 1.47
Survival of aerobic and anaerobic bacteria in purulent clinical specimens maintained in the Copan Venturi Transystem and Becton Dickinson Port-a-Cul transport systems. J Clin Microbiol (2000) 1.41
The cerebellar seizures of Hughlings Jackson. Neurology (2000) 1.40
Susceptibility of Eikenella corrodens to ten cephalosporins. Antimicrob Agents Chemother (1978) 1.35
Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538. Antimicrob Agents Chemother (1978) 1.32
Reactivation of JC virus and development of PML in patients with multiple sclerosis. Neurology (2007) 1.32
Characterization of indole-negative Bacteroides fragilis group species with use of polymerase chain reaction fingerprinting and resistance profiles. Clin Infect Dis (1996) 1.31
Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology (2003) 1.29
Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides. Antimicrob Agents Chemother (1996) 1.27
Neurosyphilis. A comparative study of the effects of infection with human immunodeficiency virus. Arch Neurol (1993) 1.26
Frequency of isolation of Porphyromonas species from infected dog and cat bite wounds in humans and their characterization by biochemical tests and arbitrarily primed-polymerase chain reaction fingerprinting. Clin Infect Dis (1996) 1.26
Eikenella corrodens in hand infections. J Hand Surg Am (1983) 1.24
Effect of carbon dioxide on erythromycin. Antimicrob Agents Chemother (1983) 1.21
Short prereduced anaerobically sterilized (PRAS) biochemical scheme for identification of clinical isolates of bile-resistant Bacteroides species. J Clin Microbiol (1990) 1.21
Management of human and animal bite wounds. Emerg Med Clin North Am (1985) 1.21
Norfloxacin, a fluoroquinolone antibacterial agent. Classification, mechanism of action, and in vitro activity. Am J Med (1987) 1.21
Dog bite wounds and infection: a prospective clinical study. Ann Emerg Med (1980) 1.19
Susceptibility of Eikenella corrodens to newer beta-lactam antibiotics. Antimicrob Agents Chemother (1980) 1.18
Cerebrovascular disease in young, HIV-infected, black Africans in the KwaZulu Natal province of South Africa. J Neurovirol (2000) 1.17
Microangiopathy of the brain, retina, and cochlea (Susac syndrome). A report of five cases and a review of the literature. Ophthalmology (1998) 1.17
Molecular targets of opiate drug abuse in neuroAIDS. Neurotox Res (2005) 1.16
Susceptibility of bite wound bacteria to seven oral antimicrobial agents, including RU-985, a new erythromycin: considerations in choosing empiric therapy. Antimicrob Agents Chemother (1986) 1.16
Chronic inflammatory polyradiculoneuropathy complicated by factor VIII antibody. Neurology (1983) 1.14
Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria. Eur J Clin Microbiol Infect Dis (2000) 1.14
Identification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringens. J Clin Microbiol (1995) 1.12
Identification and strain differentiation of 'Bacteroides fragilis group' species and Prevotella bivia by PCR fingerprinting. Anaerobe (1995) 1.12
New horizons in the bacteriology, antimicrobial susceptibility and therapy of animal bite wounds. J Med Microbiol (1998) 1.11
Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections. Antimicrob Agents Chemother (1985) 1.11
Evaluation of the RapID CB Plus system for identification of Corynebacterium species and other gram-positive rods. J Clin Microbiol (1998) 1.10
Ligandinuria in nephrotoxic acute tubular necrosis. Kidney Int (1977) 1.10
Cerebral ischemia and atrial fibrillation: prospective study. Neurology (1984) 1.09
Resistance of gram-negative bacilli as related to hospital use of antimicrobial agents. Antimicrob Agents Chemother (1983) 1.09
Paroxysmal dystonia as the initial manifestation of multiple sclerosis. Arch Neurol (1984) 1.08
Neurologic disease as the presenting manifestation of acquired immunodeficiency syndrome. South Med J (1987) 1.08
Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitals. Antimicrob Agents Chemother (1986) 1.08
A selective medium for Fusobacterium spp. J Appl Bacteriol (1991) 1.07
Cytomegalovirus. Induced demyelination associated with acquired immune deficiency syndrome. Arch Pathol Lab Med (1984) 1.07
A double-blind study comparing carbamazepine with phenytoin as initial seizure therapy in adults. Neurology (1983) 1.06
Plexiform ameloblastoma involving the maxillary antrum. A case report. N Y State Dent J (1998) 1.05
Infections following clenched-fist injury: a new perspective. J Hand Surg Am (1978) 1.05
Acute multifocal placoid pigment epitheliopathy and central nervous system involvement: nine new cases and a review of the literature. Ophthalmology (2001) 1.05
Comparison of microtiter broth dilution and agar dilution methods for susceptibility testing of Eikenella corrodens. Antimicrob Agents Chemother (1983) 1.04
Isolation of Eikenella corrodens from pulmonary infections. Am Rev Respir Dis (1979) 1.03
Effect of inoculum size on in vitro activity of norfloxacin against fecal anaerobic bacteria. Rationale for selective decontamination of the digestive tract. Am J Med (1987) 1.03
Legionnaires' disease. A cause of severe abscess-forming pneumonia. Am J Med (1979) 1.02
Bacteriology of rattlesnake venom and implications for therapy. J Infect Dis (1979) 1.02
Fastidious anaerobe agar compared with Wilkins-Chalgren agar, brain heart infusion agar, and brucella agar for susceptibility testing of Fusobacterium species. Antimicrob Agents Chemother (1990) 1.00
Survival of anaerobic bacteria in various thioglycolate and chopped meat broth formulations. J Clin Microbiol (1995) 1.00
Motor neuron disease: a paraneoplastic process associated with anti-hu antibody and small-cell lung carcinoma. Ann Neurol (1996) 1.00
Incidence and clinical significance of anaerobic bacteremia in a community hospital. Clin Infect Dis (1993) 0.99
Outpatient therapy of bite wounds. Demographic data, bacteriology, and a prospective, randomized trial of amoxicillin/clavulanic acid versus penicillin +/- dicloxacillin. Int J Dermatol (1987) 0.99
Molecular genetic analysis of the Drosophila trithorax-related gene which encodes a novel SET domain protein. Mech Dev (1999) 0.98
Staphylococcus intermedius: clinical presentation of a new human dog bite pathogen. Ann Emerg Med (1989) 0.97
Susceptibility of Eikenella corrodens to newer and older quinolones. Antimicrob Agents Chemother (1986) 0.97
Cephalosporin therapy for salmonellosis. Questions of efficacy and cross resistance with ampicillin. Arch Intern Med (1986) 0.97
Sleep disturbances in HIV-seropositive patients. JAMA (1988) 0.95
Human babesiosis. Clinical and therapeutic considerations. JAMA (1982) 0.95
CNS angiitis in graft vs host disease. Neurology (2002) 0.94
Human immunodeficiency virus type 1 infection of the brain. Clin Microbiol Rev (1993) 0.94
Does viral disease underlie ALS? Lessons from the AIDS pandemic. Neurology (2001) 0.94
Chondrosarcoma of the anterior mandible. A case report. N Y State Dent J (2000) 0.94
Neurological complications of ethylene glycol intoxication. Report of a case. Arch Neurol (1981) 0.94
Assessment of the excess risk of Salmonella dublin infection associated with the use of certified raw milk. Public Health Rep (1988) 0.93
Active bleeding in hypertensive intracerebral hemorrhage: computed tomography. Neurology (1982) 0.93
Aerobic bacterial oral flora of garter snakes: development of normal flora and pathogenic potential for snakes and humans. J Clin Microbiol (1981) 0.93
Infectious complications and therapy of bite wounds. J Am Podiatr Med Assoc (1989) 0.92
Identifying a deciduous dentigerous cyst. J Am Dent Assoc (1995) 0.91
Growth characteristics and a novel method for identification (the WEE-TAB system) of Porphyromonas species isolated from infected dog and cat bite wounds in humans. J Clin Microbiol (1997) 0.91
Sinus infection due to Eikenella corrodens. Arch Otolaryngol (1978) 0.91
CT, MR, and pathology in HIV encephalitis and meningitis. AJR Am J Roentgenol (1988) 0.90
Effect of control programs on cefazolin prescribing in a teaching hospital. Am J Hosp Pharm (1979) 0.90
Disseminated Mycobacterium marinum infection after renal transplantation. Ann Intern Med (1981) 0.90